BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,215 | -15.7% | 4,843 | +6.1% | 0.02% | -16.0% |
| Q2 2023 | $288,571 | +31.9% | 4,566 | -6.1% | 0.02% | +25.0% |
| Q1 2023 | $218,741 | -1.5% | 4,862 | +44.1% | 0.02% | -16.7% |
| Q3 2022 | $222,000 | +0.9% | 3,375 | -2.1% | 0.02% | +26.3% |
| Q1 2022 | $220,000 | -51.0% | 3,446 | -17.7% | 0.02% | -34.5% |
| Q4 2021 | $449,000 | -19.7% | 4,189 | -23.1% | 0.03% | -25.6% |
| Q3 2021 | $559,000 | -6.8% | 5,446 | -20.2% | 0.04% | -2.5% |
| Q2 2021 | $600,000 | +54.6% | 6,826 | +70.9% | 0.04% | +42.9% |
| Q1 2021 | $388,000 | -6.5% | 3,995 | +7.9% | 0.03% | -12.5% |
| Q4 2020 | $415,000 | +27.3% | 3,703 | +5.2% | 0.03% | +14.3% |
| Q3 2020 | $326,000 | -23.3% | 3,521 | -35.4% | 0.03% | -31.7% |
| Q2 2020 | $425,000 | – | 5,453 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |